Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release

被引:32
作者
Ago, Yukio [1 ]
Tanaka, Tatsunori [1 ]
Kita, Yuki [1 ]
Tokumoto, Hokuto [1 ]
Takuma, Kazuhiro [1 ]
Matsuda, Toshio [1 ,2 ,3 ]
机构
[1] Osaka Univ, Lab Med Pharmacol, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Hamamatsu Univ Sch Med, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Kanazawa Univ, United Grad Sch Child Dev, Suita, Osaka 5650871, Japan
基金
日本学术振兴会;
关键词
Lithium; Methamphetamine; Sensitization; Dopamine; Serotonin; Prefrontal cortex; IN-VIVO; NUCLEUS-ACCUMBENS; 5-HT1A RECEPTORS; FRONTAL-CORTEX; MICE; MICRODIALYSIS; CELLS; RATS;
D O I
10.1016/j.neuropharm.2011.10.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Lithium attenuates psychostimulant-induced hyperactivity and behavioral sensitization, but the exact mechanisms are not known. Previous studies show that lithium has neuromodulatory effects on monoamine systems. The present study was aimed to clarify whether prefrontal monoaminergic neurotransmission is involved in the effect of lithium on methamphetamine (METH)-induced behaviors in mice. Lithium attenuated METH-induced hyperactivity and METH-induced increase in extracellular dopamine (DA), but not serotonin (5-HT), levels in the prefrontal cortex. Chronic METH caused behavioral sensitization and enhancement of METH-induced increase in prefrontal 5-HT release (neurochemical sensitization). Co-administration of lithium with METH attenuated behavioral sensitization and neurochemical sensitization. Chronic METH also reduced the 5-HT1A receptor agonist osemozotan-induced decrease in prefrontal 5-HT release (desensitization of presynaptic 5-HT1A autoreceptor), and this effect was reversed by co-administration of lithium. These results suggest that lithium attenuates acute METH-induced hyperactivity and chronic METH-induced behavioral sensitization via modulation of prefrontal release of DA and 5-HT, respectively. The present study also suggests that a 5-HT1A receptor-mediated mechanism is involved in the effect of lithium on chronic METH-induced behavioral sensitization. (c) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1634 / 1639
页数:6
相关论文
共 28 条
[1]   Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex [J].
Ago, Y ;
Koyama, Y ;
Baba, A ;
Matsuda, T .
NEUROPHARMACOLOGY, 2003, 45 (08) :1050-1056
[2]   Selective reduction by isolation rearing of 5-HT1A receptor-mediated dopamine release in vivo in the frontal cortex of mice [J].
Ago, Y ;
Sakaue, M ;
Baba, A ;
Matsuda, T .
JOURNAL OF NEUROCHEMISTRY, 2002, 83 (02) :353-359
[3]   Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice [J].
Ago, Yukio ;
Nakamura, Shigeo ;
Kajita, Naoko ;
Uda, Misato ;
Hashimoto, Hitoshi ;
Baba, Akemichi ;
Matsuda, Toshio .
SYNAPSE, 2007, 61 (09) :757-763
[4]   Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice [J].
Ago, Yukio ;
Nakamura, Shigeo ;
Uda, Misato ;
Kajii, Yasushi ;
Abe, Michikazu ;
Baba, Akemichi ;
Matsuda, Toshio .
NEUROPHARMACOLOGY, 2006, 51 (04) :914-922
[5]   Role of Prefrontal Dopaminergic Neurotransmission in Glucocorticoid Receptor-Mediated Modulation of Methamphetamine-Induced Hyperactivity [J].
Ago, Yukio ;
Arikawa, Shinsuke ;
Yata, Miyuki ;
Yano, Koji ;
Abe, Michikazu ;
Takuma, Kazuhiro ;
Matsuda, Toshio .
SYNAPSE, 2009, 63 (01) :7-14
[6]   MONOAMINE UPTAKE INTO SYNAPTOSOMES FROM VARIOUS REGIONS OF RAT-BRAIN FOLLOWING LITHIUM ADMINISTRATION AND WITHDRAWAL [J].
AHLUWALIA, P ;
SINGHAL, RL .
NEUROPHARMACOLOGY, 1981, 20 (05) :483-487
[7]   EFFECTS OF ACUTE AND CHRONIC LITHIUM TREATMENT ON AMPHETAMINE-INDUCED DOPAMINE INCREASE IN THE NUCLEUS-ACCUMBENS AND PREFRONTAL CORTEX IN RATS AS STUDIED BY MICRODIALYSIS [J].
BAPTISTA, T ;
TENEUD, L ;
CONTRERAS, Q ;
BURGUERA, JL ;
BURGUERA, M ;
HERNANDEZ, L .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1993, 94 (02) :75-89
[8]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[9]   Effects of a chronic lithium treatment on central dopamine neurotransporters [J].
Carli, M ;
Morissette, M ;
Hebert, C ;
DiPaolo, T ;
Reader, TA .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (03) :391-397
[10]  
Carli M, 1997, SYNAPSE, V27, P83, DOI 10.1002/(SICI)1098-2396(199709)27:1<83::AID-SYN9>3.0.CO